THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 123 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242 | -16.6% | 144 | 0.0% | 0.00% | – |
| Q2 2023 | $1,490 | -4.6% | 144 | 0.0% | 0.00% | – |
| Q1 2023 | $1,562 | -3.3% | 144 | 0.0% | 0.00% | – |
| Q4 2022 | $1,616 | -19.2% | 144 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 144 | +63.6% | 0.00% | – |
| Q4 2021 | $0 | – | 88 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 88 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 88 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 88 | +57.1% | 0.00% | – |
| Q4 2020 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 56 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -50.0% | 56 | -64.1% | 0.00% | – |
| Q2 2018 | $4,000 | +100.0% | 156 | +178.6% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 56 | +55.6% | 0.00% | – |
| Q4 2017 | $2,000 | -99.0% | 36 | -99.4% | 0.00% | – |
| Q3 2016 | $210,000 | +54.4% | 5,800 | -3.2% | 0.00% | – |
| Q2 2016 | $136,000 | +23.6% | 5,992 | +3.3% | 0.00% | – |
| Q1 2016 | $110,000 | +14.6% | 5,800 | 0.0% | 0.00% | – |
| Q4 2015 | $96,000 | +50.0% | 5,800 | 0.0% | 0.00% | – |
| Q3 2015 | $64,000 | -15.8% | 5,800 | 0.0% | 0.00% | – |
| Q2 2015 | $76,000 | -24.0% | 5,800 | -0.3% | 0.00% | – |
| Q1 2015 | $100,000 | +16.3% | 5,815 | +0.3% | 0.00% | – |
| Q4 2014 | $86,000 | -68.1% | 5,800 | -50.4% | 0.00% | – |
| Q3 2014 | $270,000 | +2600.0% | 11,684 | +4014.1% | 0.00% | – |
| Q2 2014 | $10,000 | – | 284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
| Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
| Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
| CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
| Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
| Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
| Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
| Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
| DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |